Last reviewed · How we verify

NCT05761392: PreMaSy

APP-based Precise Management System of Chronic Intractable Pain

Recruiting now NA Last updated 9 March 2023
What this trial tests

NA trial testing Precise management in Pain, Chronic in 120 participants. Currently enrolling.

Timeline
26 September 2022
Primary endpoint
25 September 2026
25 September 2026

Quick facts

Lead sponsorBeijing Tsinghua Chang Gung Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment120
Start date26 September 2022
Primary completion25 September 2026
Estimated completion25 September 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Beijing Tsinghua Chang Gung Hospital

Who can join

18 and older, any sex, with Pain, Chronic or Pain, Intractable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn about a new management system in chronic and stubborn pain patients who accept therapy of spinal cord stimulation (SCS). Usually, these patients are required to take long-term follow-ups to ensure that the stimulator works well. The main questions it aims to answer are: * Is it better to improve the patient's quality of life than the current conventional follow-up? * Is it better to relieve pain in the long term than the current conventional follow-up? * Is it possible to be applied to a large population of chronic pain patients? Participants will be randomly assigned to either a control group or an interventional group. Participants in the control group will be given the standard SCS implantation surgery and asked to complete the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Participants in the interventional group will be given the standard SCS implantation surgery and asked to do the following things: * Take the daily pain self-assessment questions on a mobile phone APP. * Take the monthly healthy status self-assessment questionnaires on a mobile phone APP. * Take the conventional follow-up (at least 1-, 3-, and 6-month post-operative). Researchers will compare the two groups to see if the life quality of the interventional group is improved.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Precise management system for chronic intractable pain patients implanted with spinal cord stimulation based on a remote programming platform: study protocol for a randomized controlled trial (PreMaSy study).
    Cheng Y, Xie D, Han Y, Guo S, et al · · 2023 · cited 1× · PMID 37691092 · DOI 10.1186/s13063-023-07595-4

Verify or expand the search:

Other recruiting trials for Pain, Chronic

Currently open trials in the same condition.

Other Beijing Tsinghua Chang Gung Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05761392.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing